SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001535264-18-000034
Filing Date
2018-02-13
Accepted
2018-02-13 16:06:01
Documents
1
Group Members
ADAM C. STETTNERAUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS LLCMG ADVISERS LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 TRILLIUM 13G trillium13gt.txt SC 13G 8558
  Complete submission text file 0001535264-18-000034.txt   10556
Mailing Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022
Business Address 527 MADISON AVENUE SUITE 2600 NEW YORK NY 10022 212-319-6670
AWM Investment Company, Inc. (Filed by) CIK: 0001535264 (see all company filings)

IRS No.: 113086452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: SC 13G | Act: 34 | File No.: 005-88719 | Film No.: 18603276
SIC: 2834 Pharmaceutical Preparations